Press Release|

SHL attends the 2020 PDA in virtual fashion

2020 Pda Newspage

SHL will join the 2020 Parenteral Drug Association’s annual Universe of Pre-Filled Syringes and Injection Devices virtual event with the launch of our virtual experience platform. Visitors can attend the event through the PDA’s online platform that comprises live chat sessions, conference presentations, and company pages.  

In line with PDA’s digitalized strategy and in response to many inquiries from our partners and customers who have not been able to visit the SHL site due to this year’s special circumstances, SHL will also launch a webpage titled The SHL Experience to showcase the processes behind the making of our devices. The SHL Experience is rich with informative content and interactive elements, boasting our capabilities in fine machinery and expertise, while detailing our end-to-end processes, from design and development to mass production and quality control. Also, the webpage features a sophisticated design as well as a simple and intuitive interface that allows user to navigate its contents easily.

Global marketing director Magnus Fastmarken said, “The current state of the global pandemic has determined the course of digital marketing, driving companies to find new tools for effective communication with customers or business partners. For SHL, staying at the forefront of industry trends not only means providing our customers with the best products, but also finding the best way to communicate with them. SHL is poised for this new normal era.”

In addition to the premier of our virtual experience webpage, SHL experts will also give a total of four presentations while our partners at Innovation Zed will present a poster presentation at the online conference. Interested participants will have the opportunity to join our speakers at the live Q&A during the given time (EDT) for each session as follows:

Topic

Speaker

Time

Customizing Platform Devices: A Review of Molly’s Flexible Design and Development Model

Josh Gonzalez, Chief Commercial Officer, SHL Medical

Oct 6

11:00 am – 11:15 am Tech Talk

Characterization of a Novel Mini Bag Primary Packaging Technology

Hans Peter Manser, Senior Director of Business Development, SHL Medical 

 

Christoph Egloff, Senior Manager of Innovation and Development, SHL Medical 

Oct 7

Session A3

11:35 am – 11:55 am 

 

From Self-Administration to Self-Management: a Digital Health Reformulation for the Drug Delivery Industry

Ramin Rafiei, PhD, Director of Digital Healthcare, SHL Medical

 

Rasmus Renstad, PhD, Director of Innovation, SHL Medical

Oct 7

Session C3

11:15 am – 12:15 pm

Case Study: Key Transformation Considerations for the Design, Development, and Manufacturing of Connected Devices

Dewi Kodrat, Manager of Engineering Solutions, SHL Medical

Oct 8

Session P4

10:00 am – 10:20 am 

Poster Presentation-Insulcheck Connect

Dean Minnock, CEO, Innovation Zed

 

Oct 5-8

12:15 pm – 2:30 pm

Visitors are also encouraged to check into the chatroom to speak with SHL experts about our products or company information. Our experts will be standing by to answer visitors’ questions.  To access The SHL experience, click here.

About SHL

SHL Group is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit www.shl.group

Media contact: info@shl-group.com

Share:

Related News